Caspofungin vs fluconazole for invasive fungal disease in AML

Study of 517 patients aged three months to 30 years with newly diagnosed de novo, relapsed or secondary acute myeloid leukaemia.
Study of 517 patients aged three months to 30 years with newly diagnosed de novo, relapsed or secondary acute myeloid leukaemia.
Tjenesten du prøver å få tilgang til er bare tilgjengelig for registrerte brukere. For å fortsette vennligst logg inn eller registrer deg for en gratis konto på Univadis